In the wake of FDA rejection, concern mounts over lack of drugs to treat …

In the wake of FDA rejection, concern mounts over lack of drugs to treat …

As news emerged last week of plans by Sprout Pharmaceuticals to appeal the FDA's decision not to approve flibanserin, a non-hormonal pill meant to boost a woman's libido, discussion once again ensued about the lack of treatment options for women, even 

8
Like
Save

Comments

Write a comment

*